References
- Sonoo M, Idogawa M, Kanbayashi T, et al. [COVID-19 in Japan: insights from the epidemiological data]. Brain and Nerve Japanese . 2020;72(10):1023–1030. .
- Ministry of Health, Labour and Welfare. Novel coronavirus (COVID-19) [Internet] [cited 2021 Jul 26]. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000164708_00079.html2021; 2021.
- Thompson MK, Kalkowska DA, and Badizadegan K. Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions. Expert Rev Vaccines 2021;20(4):465–481.
- Thompson MK, Kalkowska DA, and Badizadegan K. Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication. Expert Rev Vaccines 2021;20(4):449–460.
- Ministry of Health, Labour and Welfare. Coronavirus (COVID-19). vaccinations [Internet]. [cited 2021 Jul 26]. Available from: https://v-sys.mhlw.go.jp/en/8; 2021.
- Saitoh A, Okabe N. Progress and challenges for the Japanese immunization program: beyond the “vaccine gap.” Vaccine. 2018;36(30):4582–4588.
- Nakayama T. Vaccine chronicle in Japan. J Infect Chemother. 2013;19(5):787–798.
- Hoshina T, Kawase M, Watanabe S, et al. Trends in voluntary vaccination coverage in a Japanese city. Pediatr Int. 2021. DOI:https://doi.org/10.1111/ped.14712.
- Saitoh A, Okabe N. Current issues with the immunization program in Japan: can we fill the “vaccine gap”? Vaccine. 2012;30(32):4752–4756.
- Pharmaceutical and Medical Devices Agency. PMDA’s efforts to combat COVID-19 [Internet] [cited 2021 Jul 26]. Available from: https://www.pmda.go.jp/english/about-pmda/0002.html 2021.
- Simms KT, Hanley SJB, Smith MA, et al. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Health. 2020;5(4):e223–e234.
- Hanley SJ, Yoshioka E, Ito Y, et al. HPV vaccination crisis in Japan. Lancet. 2015;385(9987):2571.
- Kawado M, Hashimoto S, Ohta A, et al. Estimating nationwide cases of sexually transmitted diseases in 2015 from sentinel surveillance data in Japan. BMC Infect Dis. 2020;20(1):77.
- Japan approves MSD’s 9-Valent HPV vaccine 5 years after filing 2020 [cited 2021]. Available from: https://pj.jiho.jp/article/242550.
- Ueda Y, Yagi A, Ikeda S, et al. Beyond resumption of the Japanese government’s recommendation of the HPV vaccine. Lancet Oncol. 2018;19(12):1563–1564.
- Japan to resume active promotion of HPV vaccinations. Tokyo: JIJI press: https://jen.jiji.com/jc/eng?g=eco&k=2021111200936; Accessed 12 November 2021 2021
- Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228.
- Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):120.
- Guidry JPD, Laestadius LI, and Vraga EK, et al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021;49(2):137–142.
- Kelly BJ, Southwell BG, and McCormack LA, et al. Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infect Dis. 2021;21(1):338.
- Dror AA, Eisenbach N, and Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–779.
- Fisher KA, Bloomstone SJ, and Walder J, et al. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults Ann Intern Med. 2020;173(12):964–973.
- Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines (Basel). 2021;9(1):48.
- Machida M, Nakamura I, Kojima T, et al. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. Vaccines (Basel). 2021;9(3):210.
- Kadoya Y, Watanapongvanich S, Yuktadatta P, et al. Willing or hesitant? A socioeconomic study on the potential acceptance of COVID-19 vaccine in Japan. Int J Environ Res Public Health. 2021;18(9):4864.
- Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—A checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–413.
- Trapero-Bertran M, Rodríguez-Martín B, López-Bastida J. What attributes should be included in a discrete choice experiment related to health technologies? A systematic literature review. PLOS ONE. 2019;14(7):e0219905.
- Igarashi A, Goto R, Yoneyama-Hirozane M. Willingness to pay for QALY: perspectives and contexts in Japan. J Med Econ. 2019 Oct;22(10):1041–1046.
- Portal site of official statistics of Japan. Stat. Jpn. 2021. [cited 2021 Jul 26]. Available from:2021. Available from: https://www.e-stat.go.jp/en/stat-search?page=1&query=population&layout=dataset.
- Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci USA. 2021;118(10):e2021726118.
- Ii M, Ohkusa Y. Nihon Koshu Eisei zasshi. [An empirical research for demand of influenza vaccination]. Nihon Koshu Eisei Zasshi. 2001;48(1):16–27. Japanese.
- Kreps S, Prasad S, Brownstein JS, et al. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Network Open. 2020;3(10):e2025594.
- Kreps SE, Kriner DL. Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: evidence from a conjoint experiment. Vaccine. 2021;39(24):3250–3258.
- Bhatia S, Walasek L, Slovic P, et al. The more who die, the less we care: evidence from natural language analysis of online news articles and social media posts. Risk Anal. 2021;41(1):179–203.
- Maeda H. Japan’s special approval for emergency system during COVID-19 pandemic. Clin Pharmacol Ther. 2021. DOI:https://doi.org/10.1002/cpt.2310
- Centers for Disease Control and Prevention. MMWR Morb. cited 2021 Jul 26]. Available from:2021. Available from Mortal Wkly Rep. 2021;: https://www.cdc.gov/mmwr/volumes/69/wr/mm695152e2.htm